Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi004-A) from a Wilson's disease patient harboring a homozygous Pro992Leu mutation in ATP7B gene

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi004-A) from a Wilson's disease patient harboring a homozygous Pro992Leu mutation in ATP7B gene

Human IPSC Line, ZZUNEUi004-A, was generated from a 34-year-old male patient with Wilson's Disease carrying a homozygous Pro992Leu mutation in ATP7B gene, using non-integrative reprogramming method. This cell line shows pluripotency both in vitro and vivo, and has a normal karyotype.

Bibliographic Details
Main Authors:	Jiwei Zhang, Liting Wei, Dingbang Chen, Li Feng, Chao Wu, Rui Wang, Xunhua Li, Hongbo Liu
Format:	Article
Language:	English
Published:	Elsevier 2020-04-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506120300453

Similar Items

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi005-A) from a Wilson's disease patient harboring a homozygous Pro992Leu mutation in ATP7B gene
by: Liting Wei, et al.
Published: (2020-08-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi003-A) from a Wilson's disease patient harboring a homozygous R778L mutation in ATP7B gene
by: Jiwei Zhang, et al.
Published: (2019-12-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi001-A) from a healthy male individual
by: Jiwei Zhang, et al.
Published: (2020-05-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi002-A) from a patient with spinocerebellar ataxia type 3
by: Liting Wei, et al.
Published: (2020-08-01)

Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene
by: Shu-Hong Wang, et al.
Published: (2020-12-01)

Induced pluripotent stem cell (iPSC) line (ZZUNEUi009-A) from a healthy female individual
by: Mengduan Liu, et al.
Published: (2021-05-01)

Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene
by: Guangli Guo, et al.
Published: (2021-05-01)

Generation of a human iPSC line ZZUNEUi015-A from a patient with hypertrophic cardiomyopathy caused by mutation in ALPK3
by: Xiaoxu Tian, et al.
Published: (2021-04-01)

Generation of autism spectrum disorder patient-derived iPSC line SDUKIi004-A
by: Morad Kamand, et al.
Published: (2020-12-01)

Generation of an iPSC line (AKOSi004-A) from fibroblasts of a female adult NPC1 patient, carrying the compound heterozygous mutation p.Val1023Serfs*15/p.Gly992Arg and of an iPSC line (AKOSi005-A) from a female adult control individual
by: Christin Völkner, et al.
Published: (2021-01-01)

Development of a human iPSC line (SMBCi004-A) from a patient with Gaucher disease
by: Qingyang Zhao, et al.
Published: (2020-10-01)

Generation of human control iPSC line CHOPi004-A from juvenile foreskin fibroblast cells
by: Somdutta Mukherjee, et al.
Published: (2020-12-01)

An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene
by: Xiaowei Li, et al.
Published: (2020-08-01)

Generation of a hiPSC line ZZUNEUi012-A from a healthy female individual
by: Mengyu Wang, et al.
Published: (2021-01-01)

Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors
by: Sunao Sugita, et al.
Published: (2016-10-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene
by: Bailing Zu, et al.
Published: (2021-10-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus
by: Stefanie Schuster, et al.
Published: (2019-01-01)

Generation of an iPSC line from a patient with infantile liver failure syndrome 2 due to mutations in NBAS: DHMCi004-A
by: Dominic Lenz, et al.
Published: (2019-03-01)

Generation of two iPSC lines (FAMRCi004-A and FAMRCi004-B) from patient with familial progressive cardiac conduction disorder carrying genetic variant DSP p.His1684Arg.
by: Aleksandr Khudiakov, et al.
Published: (2020-03-01)

The CIRM iPSC repository
by: Stephen S. Lin, et al.
Published: (2020-04-01)

Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN
by: Shujian Huang, et al.
Published: (2021-04-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
by: Tadaaki Hanatani, et al.
Published: (2021-01-01)

Generation of iPSC line MU011.A-hiPS from homozygous α-thalassemia fetal skin fibroblasts
by: Amornrat Tangprasittipap, et al.
Published: (2015-11-01)

Human Genomic Safe Harbors and the Suicide Gene‐Based Safeguard System for iPSC‐Based Cell Therapy
by: Yasuyoshi Kimura, et al.
Published: (2019-07-01)

Generation and characterization of a human iPSC line (UAMi004-A) from a patient with propionic acidemia due to defects in the PCCB gene
by: Arístides López-Márquez, et al.
Published: (2019-07-01)

Generation of a human iPSC line, INMi004-A, with a point mutation in CRX associated with autosomal dominant Leber congenital amaurosis
by: Nejla Erkilic, et al.
Published: (2019-07-01)

Induced pluripotent stem cell (iPSC) line MLi-004A derived from a patient with recessive dystrophic epidermolysis bullosa (RDEB)
by: Sandra Ropret, et al.
Published: (2021-08-01)

Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7
by: Xiaowei Li, et al.
Published: (2020-03-01)

Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling
by: Arantxa Bolinches-Amorós, et al.
Published: (2019-07-01)

iPSC for modeling neurodegenerative disorders
by: Valeria Valadez-Barba, et al.
Published: (2020-12-01)

Maturing iPSC-Derived Cardiomyocytes
by: Bor Luen Tang
Published: (2020-01-01)

iPSC Bioprinting: Where are We at?
by: Sara Romanazzo, et al.
Published: (2019-08-01)

Establishment of an iPSC line (CSUXHi004-A) from a patient with Waardenburg syndrome type I caused by a PAX3 splice mutation
by: Jie Wen, et al.
Published: (2021-05-01)

A study on Jingjue Renyue (992-1064)
by: Wang, Hsueh-Fen, et al.
Published: (2015)

Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene
by: Nidaa A. Ababneh, et al.
Published: (2020-10-01)

Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts
by: María Questa, et al.
Published: (2016-03-01)

Establishment of human iPSC line from patient of Indian ethnicity carrying homozygous CD8/9 (+G) beta thalassemia mutation
by: Shruti Tembe, et al.
Published: (2020-04-01)

Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene
by: Henriette R. Frederiksen, et al.
Published: (2019-03-01)

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line
by: Benjamin Schmid, et al.
Published: (2019-01-01)

The Global Alliance for iPSC Therapies (GAiT)
by: Stephen Sullivan, et al.
Published: (2020-12-01)